← FDA Drug Approvals (Drugs@FDA)
DICLOFENAC SODIUM
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: RUBICON RESEARCH · Approved 2023-05-11
Drug application
- FDA Application #
ANDA216548- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DICLOFENAC SODIUM
- Generic name
- DICLOFENAC SODIUM
- Active ingredients
- DICLOFENAC SODIUM
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- RUBICON RESEARCH
- Manufacturer
- NorthStar Rx LLC
- First approval
- 2023-05-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown